Inhibition by pargyline of cardiovascular amine oxidase activity.
D000818:Animals; D001808:Blood Vessels / Q000201:enzymology*; D003010:Clorgyline / Q000494:pharmacology; D003471:Cuprizone / Q000494:pharmacology; D004355:Drug Stability; D066298:In Vitro Techniques; D008297:Male; D008638:Mesenteric Arteries / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors; D009206:Myocardium / Q000201:enzymology*; D009638:Norepinephrine; D010293:Pargyline / Q000494:pharmacology*; D010627:Phenethylamines; D010648:Phenylacetates / Q000032:analysis; D051381:Rats; D012663:Semicarbazides / Q000494:pharmacology; D013997:Time Factors
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D010648:Phenylacetates; D012663:Semicarbazides; D003471:Cuprizone; D010293:Pargyline; D008995:Monoamine Oxidase; D003010:Clorgyline; D009638:Norepinephrine